BH (Byungho) 

Hyun

Senior Client Partner

BH (Byungho) Hyun is a Senior Client Partner and a responsible member of the Global Life Science (GLM) practice in Korea. 

Mr. Hyun has over 20 years of experiences in management consulting, corporate strategy, marketing/sales strategy, new business development, organizational restructuring, commercial excellence, new commercial model development and M&A practices in the Korean Life Science & Healthcare sector.

Prior to joining Korn Ferry, Mr. Hyun was the team leader of IMS Consulting Group (now IQVIA) in Korea, the global leading strategy firm in the Life Science & Healthcare sector. At IMS Consulting Group in Korea, Mr. Hyun led diversified healthcare-focused strategic commercial projects for pharmaceuticals,  medical devices companies, healthcare providers and even Korean conglomerates.

Earlier, he was a strategy consultant with Monitor Group and was exposed to quite broad Korean industries such as Semiconductor, Electronic Consumers, IT, E-Commerce, Construction, Shipbuilding, and Automotive, including the Life Science industry. There, he conducted new growth engine development, organization redesign, in-organic growth strategy, and commercial excellence.

He began his business career with LG Life Sciences, where he developed the new global business with the first Korean new drug approved by US FDA, FACTIVE.

Mr. Hyun earned an MBA from The Tuck School of Business, Dartmouth College in 2006, with concentrations in healthcare and consulting. He received a bachelor’s degree in Life Science from POSTECH. His professional life has been fully dedicated to Life Science business.